Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN112047933B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112047933B discloses a novel quinazolinone USP7 inhibitor synthesis with high yield and mild conditions, offering cost-effective solutions for pharmaceutical intermediates.